Internal Medicine

Pneumonia

Lung Inflammation and Infection

Amos Asamoah
October 2025
6 min read
Other Topics

We're continuing our respiratory journey with pneumonia - one of the most common and serious lung infections worldwide. Pneumonia represents inflammation and consolidation of lung tissue, typically caused by infectious agents. I'll guide you through the different types of pneumonia, their characteristic pathogens, clinical presentations, and evidence-based management approaches. Understanding pneumonia is crucial as it remains a leading cause of hospitalization and mortality across all age groups. Let's dive into the world of lung infections and learn how to recognize and manage them effectively!

🩺 Definition and Classification

Pneumonia is defined as an acute respiratory illness associated with recently developed radiological pulmonary shadowing, which may be segmental, lobar, or multilobar. Classification helps guide diagnosis and treatment.

By Anatomical Distribution

  • Lobar pneumonia: Entire lobe involvement
  • Bronchopneumonia: Patchy distribution
  • Interstitial pneumonia: Supportive tissue involvement
  • Necrotizing pneumonia: Tissue destruction

By Clinical Setting

  • Community-acquired (CAP): Outside healthcare settings
  • Hospital-acquired (HAP): ≥48 hours after admission
  • Ventilator-associated (VAP): >48 hours after intubation
  • Healthcare-associated (HCAP): Recent healthcare exposure
Type Typical Pathogens Clinical Features Common Settings
Community-Acquired S. pneumoniae, H. influenzae, viruses Acute onset, fever, productive cough Otherwise healthy individuals
Atypical Mycoplasma, Legionella, Chlamydia Gradual onset, extrapulmonary symptoms All ages, crowded settings
Hospital-Acquired Gram-negative rods, S. aureus, MRSA Often subtle, in compromised hosts Hospitalized patients
Aspiration Oral anaerobes, mixed flora Dependent lung segments, foul sputum Impaired consciousness, dysphagia
Clinical Pearl: Remember that "typical" pneumonia presents with abrupt onset, high fever, productive cough, and lobar consolidation, while "atypical" pneumonia has gradual onset, dry cough, extrapulmonary symptoms, and patchy infiltrates.

🔄 Pathophysiology

Pneumonia develops when pathogens overcome host defenses and establish infection in the lung parenchyma, triggering an inflammatory response.

Routes of Infection

  • Aspiration: Most common route
  • Inhalation: Airborne droplets
  • Hematogenous: Bloodstream spread
  • Direct spread: From adjacent structures

Host Defense Breach

  • Impaired cough reflex
  • Damaged mucociliary clearance
  • Altered microbiome
  • Immune suppression

Inflammatory Response

  • Alveolar macrophage activation
  • Neutrophil recruitment
  • Cytokine release
  • Capillary leak and consolidation
Tutor Tip: Think of pneumonia development as a balance between microbial virulence factors and host defense mechanisms. When defenses are compromised or pathogens are particularly virulent, infection establishes.

👨‍⚕️ Clinical Presentation

Pneumonia symptoms vary based on the causative organism, patient factors, and severity, but typically include respiratory and systemic manifestations.

Common Symptoms

Typical Pneumonia

  • Acute onset fever and chills
  • Productive cough (rusty sputum in pneumococcal)
  • Pleuritic chest pain
  • Dyspnea, tachypnea
  • Consolidation findings on exam

Atypical Pneumonia

  • Gradual onset over days
  • Dry, non-productive cough
  • Prominent extrapulmonary symptoms
  • Headache, myalgias, fatigue
  • Minimal findings on lung exam

Physical Examination Findings

Finding Description Significance
Dullness to percussion Impaired resonance over consolidated area Indicates alveolar filling/consolidation
Bronchial breath sounds Harsh, tubular sounds over consolidation Sound transmission through solid lung
Egophony (E→A change) "E" sounds like "A" through consolidation Increased sound transmission
Whispered pectoriloquy Clear transmission of whispered sounds Classic sign of consolidation
Crackles/rales Discontinuous sounds during inspiration Air moving through fluid-filled airways
Severe Pneumonia: Defined by CURB-65 criteria (Confusion, Urea >7 mmol/L, Respiratory rate ≥30, BP systolic <90 or diastolic ≤60, age ≥65). Score ≥2 indicates severe pneumonia requiring hospitalization.

🔍 Diagnostic Approach

Diagnosis involves clinical assessment combined with imaging and laboratory studies to confirm pneumonia, identify severity, and guide antimicrobial therapy.

Diagnostic Workup

Test Purpose Key Findings Limitations
Chest X-ray Confirm diagnosis, assess extent Consolidation, infiltrates, effusions May be normal early, poor for some pathogens
Complete Blood Count Assess inflammatory response Leukocytosis with left shift May be normal in elderly/immunocompromised
Blood Cultures Identify bacteremia, guide therapy Positive in 5-15% of CAP cases Low yield, but crucial when positive
Sputum Gram Stain/Culture Identify causative organism Predominant organism, PMNs Quality dependent, prior antibiotics affect yield
Procalcitonin Differentiate bacterial vs viral Elevated in bacterial pneumonia Not perfect, clinical correlation needed
Urinary Antigens Rapid diagnosis of specific pathogens Legionella, S. pneumoniae Limited to specific organisms
Important: Always assess severity using validated scores (CURB-65, PSI/PORT) to determine appropriate treatment setting (outpatient vs inpatient vs ICU).

💊 Management Strategies

Management involves appropriate antimicrobial therapy based on likely pathogens, supportive care, and monitoring for complications.

Empirical Antibiotic Selection

Setting Common Pathogens First-line Therapy Alternatives/Special Considerations
Outpatient CAP S. pneumoniae, H. influenzae, atypicals Amoxicillin or Doxycycline Macrolide, respiratory fluoroquinolone
Inpatient CAP (non-ICU) S. pneumoniae, H. influenzae, atypicals, enteric GNR β-lactam + Macrolide or Respiratory FQ Consider local resistance patterns
ICU CAP S. pneumoniae, S. aureus, Legionella, GNR β-lactam + Macrolide or Respiratory FQ Add MRSA coverage if risk factors
Hospital-Acquired GNR, S. aureus, Pseudomonas Antipseudomonal β-lactam Add MRSA/anaerobic coverage as needed
Aspiration Oral anaerobes, mixed flora β-lactam/β-lactamase inhibitor Clindamycin, Carbapenem

Supportive Care and Monitoring

General Measures

  • Oxygen to maintain SpO2 >90%
  • Hydration and nutrition
  • Fever control (antipyretics)
  • Analgesia for pleuritic pain
  • Bronchodilators if wheezing

Monitoring Parameters

  • Vital signs (especially temp, RR, O2 sat)
  • Mental status changes
  • Serial chest exams
  • Laboratory trends (WBC, inflammatory markers)
  • Radiographic improvement
Treatment Duration: Typical CAP treatment is 5-7 days, extending to 7-14 days for severe cases or specific organisms (e.g., Legionella, Staphylococcus). Always individualize based on clinical response.

⚠️ Complications and Special Considerations

Pneumonia can lead to serious complications, and certain populations require special consideration in diagnosis and management.

Common Complications

  • Pleural effusion: Common, often sterile
  • Empyema: Infected pleural space
  • Lung abscess: Necrotic cavity formation
  • Respiratory failure: Requiring mechanical ventilation
  • Sepsis and shock: Systemic inflammatory response

Special Populations

  • Elderly: Atypical presentation, higher mortality
  • Immunocompromised: Unusual pathogens, rapid progression
  • Alcoholics: Aspiration risk, Klebsiella consideration
  • Nursing home: Multidrug-resistant organisms
  • COPD patients: Higher risk, consider Pseudomonas
Clinical Insight: Always consider tuberculosis in patients with subacute symptoms, night sweats, weight loss, upper lobe infiltrates, or inadequate response to conventional antibiotics, especially in high-risk populations.

🌱 Prevention and Vaccination

Prevention is a crucial component of pneumonia management, particularly through vaccination and addressing modifiable risk factors.

Vaccination Strategies

  • Pneumococcal vaccines: PCV13 and PPSV23
  • Influenza vaccine: Annual vaccination
  • COVID-19 vaccine: Per current guidelines
  • Haemophilus influenzae type b: Childhood series

Risk Factor Modification

  • Smoking cessation
  • Alcohol moderation
  • Good oral hygiene
  • Chronic disease management
  • Infection control measures

Special Situations

  • Post-splenectomy prophylaxis
  • Immunocompromised host strategies
  • Aspiration precautions
  • Healthcare-associated prevention
Pro Tip: Follow current CDC/ACIP guidelines for pneumococcal vaccination, which recommend sequential administration of PCV13 and PPSV23 in appropriate populations for optimal protection.

🧠 Key Takeaways

  • Pneumonia classification by setting (CAP, HAP, VAP) guides likely pathogens and empirical therapy
  • Typical vs atypical pneumonia have distinct clinical presentations and common pathogens
  • Diagnosis requires clinical assessment plus radiologic confirmation
  • Severity scoring (CURB-65, PSI) determines treatment setting and intensity
  • Empirical antibiotic selection is based on patient factors, setting, and local resistance patterns
  • Supportive care includes oxygen, hydration, and symptom management
  • Complications include pleural effusion, empyema, abscess, and respiratory failure
  • Prevention through vaccination and risk factor modification is essential

🧭 Conclusion

We've thoroughly explored pneumonia, student—from its varied presentations to evidence-based management strategies. Remember that pneumonia remains a significant cause of morbidity and mortality worldwide, and your ability to recognize different types, assess severity appropriately, and initiate timely treatment can dramatically impact patient outcomes. I encourage you to master severity scoring systems and understand the rationale behind empirical antibiotic selection. Excellent work building your infectious disease knowledge! Next, we'll examine tuberculosis, a persistent global health challenge with unique diagnostic and management considerations.

In pneumonia management, timely appropriate antibiotics save lives, but don't forget the importance of supportive care and prevention.

← Previous Topic: Asthma and COPD Next Topic: Tuberculosis →